Clinical Trials · NCT02025179

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

CompletedPhase 2Teriparatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Northwestern University
Enrollment
25
Start date
Jan 2013
Locations
1 site, United States
Primary endpoint
Bone Mineral Density (BMD) of the Total Hip as Assessed by Dual-energy X-ray Absorptiometry (DXA)
View Teriparatide compound reference